Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
World J Clin Cases ; 11(34): 8219-8227, 2023 Dec 06.
Artículo en Inglés | MEDLINE | ID: mdl-38130784

RESUMEN

BACKGROUND: Frostbite is becoming increasingly common in urban environments, and severe cases can lead to tissue loss. The treatment goal is to preserve tissue and function; the sooner appropriate treatment is administered, the more tissue can be saved. However, not every patient with deep frostbite seeks medical care promptly. CASE SUMMARY: We report the case of a 73-year-old male patient who was lost in the wilderness for 2 d due to trauma and confusion. He experienced deep frostbite on multiple fingers. Treatment should not be discontinued for patients with deep frostbite who present after the optimum treatment timing. Bullae that no longer form (bloody) blisters within 24 h of aspiration should be removed. Mucopolysaccharide polysulfate cream has clinical value in frostbite treatment. The patient was transferred to Chinese Academy of Medical Sciences and Peking Union Medical College Hospital 12 h after being rescued. The patient had contraindications for thrombolysis, the most effective treatment, due to intracranial hemorrhage and presenting past the optimum treatment timing. We devised a comprehensive treatment plan, which involved delayed use vasodilators and high-pressure oxygen therapy at day 49 post-injury. We experimented with mucopolysaccharide polysulfate cream to treat the frostbite. The aim of the treatment was to safeguard as much tissue as possible. In the end, the fingers that suffered from frostbite were able to be partially preserved. CONCLUSION: The case indicated that patients with severe frostbite who missed the optimal treatment time and had contraindications for thrombolysis could still partially preserve the affected limbs through comprehensive treatment.

2.
Guang Pu Xue Yu Guang Pu Fen Xi ; 36(5): 1418-22, 2016 May.
Artículo en Chino | MEDLINE | ID: mdl-30001018

RESUMEN

Suaeda salsa(S.salsa) is a typical vegetation of coastal wetland in the north of Liaodong Bay. The S. salsa biomass assessment plays an important role in understanding the ecosystem productivity of coastal wetland and the formation of ecosystem structure and function. Usually the S.salsa coverage is inhomogeneous. The low S.salsa coverage can be found at a natural condition, the soil background has a strong influence on S.salsa spectral data. The Transformed Soil Adjusted Vegetation Index (TSAVI) used as independent variable was derived by the Landsat 8 OLI simulation data. The S.salsa biomass inversion models were built based on the regression analysis of TSAVI and ground measured biomass in this study. The correlation between TSAVI (600~687, 820~880 nm) and biomass was significant, the correlation coefficient was about 0.9, up to 0.92. The results of linear and quadratic models were better than those of logarithmic, exponential and power models, the determination coefficient r2 of linear and quadratic models were 0.83. Combined with F value and operation efficiency, the linear model was the best option for mature S.salsa biomass inversion. The linear model was applied to invert the S.salsa biomass by using the Landsat 8 OLI data in the study area and it was further validated using in-situ data. The correlation coefficient between the in-situ value and retrieved value was 0.962, the relative error was 0.106. For higher S.salsa coverage, the relative error was lower. The relative error of the low-cover S.salsa biomass inversion was around 0.18. The results showed that the established model has good accuracy for different coverage. In addition, with the introduction of ±5% error of soil line parameters a and b, the average relative errors were relatively stable, and the correlation coefficients were reduced, but all the correlative coefficients were above 0.9. The results showed that the established model is stable.

3.
Brain Res ; 1562: 100-8, 2014 May 08.
Artículo en Inglés | MEDLINE | ID: mdl-24675030

RESUMEN

The current study was performed to evaluate the mechanisms and therapeutic effects of overexpressing neuroglobin (Ngb) on spinal cord injury (SCI). Adeno-associated virus (AAV) was injected in the T12 section 7 days before SCI. Animals were randomly divided into four groups: a sham group, a vehicle group, an AAV-EGFP group and an AAV-Ngb group. Recovery of hind limb locomotor function was determined during the 3-week post operation period by the Basso, Beattie and Bresnahan locomotor rating scale. At 24 h after SCI and at the end of the study, the segments of spinal cord, centered with the lesion site were harvested for histopathological analysis. Immunofluorescence was performed using antibodies to recognize neuN in the lesion sections. At 24 h after SCI, the spinal cord tissue samples were removed to analyze tissue concentrations of superoxide dismutase (SOD) and malondialdehyde (MDA). Apoptotic cells were assessed using a terminal deoxynucleotidyl transferase, dUTP nick end labeling (TUNEL) kit. The expression of bcl-2, bax, cytochrome c, and cleaved caspase-3, were determined by Western blot assay and immunostaining analysis. The results showed that animals overexpressing Ngb had significantly greater recovery of locomotor function, less neuronal loss and fewer apoptotic cells. In addition, overexpressing Ngb significantly increased bcl-2 expression and SOD level, decreased bax expression, attenuated the release of cytochrome c from mitochondria to the cytosol fraction, and reduced the activity of caspase-3 and MDA level after SCI. These findings suggest, that overexpressing Ngb can significantly improve the recovery of locomotor function. This neuroprotective effect may be associated with the inhibition of neural apoptosis via the mitochondrial pathway.


Asunto(s)
Terapia Genética , Globinas/genética , Globinas/metabolismo , Proteínas del Tejido Nervioso/genética , Proteínas del Tejido Nervioso/metabolismo , Neuronas/fisiología , Recuperación de la Función/fisiología , Traumatismos de la Médula Espinal/terapia , Médula Espinal/fisiopatología , Animales , Apoptosis/fisiología , Supervivencia Celular/fisiología , Dependovirus , Vectores Genéticos , Miembro Posterior , Masculino , Actividad Motora , Neuroglobina , Oxidación-Reducción , Distribución Aleatoria , Ratas Sprague-Dawley , Traumatismos de la Médula Espinal/fisiopatología , Vértebras Torácicas
4.
Oncol Res ; 20(7): 319-26, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23879172

RESUMEN

The mTOR pathway is a central control of cell growth, proliferation, metabolism, and survival, and is deregulated in most cancers. Cancer cells are addicted to increased activity of mTOR kinase-mediated signaling pathways, leading to numerous inhibitors of mTOR signaling in preclinic and clinical trials for cancer therapy. Phosphorus-containing sirolimus (FIM-A), which targets mTOR signaling, inhibits cancer cell growth in vitro. Here we report that FIM-A reduces the angiogenesis and proliferation of osteosarcoma both in vitro and in vivo. In cultured osteosarcoma cell lines, FIM-A inhibited cell proliferation and arrested cells in the G1 phase of the cell cycle, accompanied with reduction of VEGF and HIF-1alpha. With in vivo mouse osteosarcoma xenografts, FIM-A treatment resulted in the inhibition of mTORC1 signaling as demonstrated by the decreased phosphorylation of p70S6K1 and 4E-BP1. Consistent with this finding, FIM-A significantly decreased the average tumor volume, nuclei staining of PCNA, and the number of intratumoral microvessels. Our data demonstrated that targeting mTORC1 by FIM-A inhibited the growth of osteosarcoma in vitro and in vivo, providing the basis for further development of FIM-A as a therapy for osteosarcoma patients.


Asunto(s)
Antineoplásicos/farmacología , Neoplasias Óseas/tratamiento farmacológico , Proliferación Celular/efectos de los fármacos , Neovascularización Patológica/tratamiento farmacológico , Osteosarcoma/tratamiento farmacológico , Sirolimus/análogos & derivados , Inhibidores de la Angiogénesis/farmacología , Animales , Línea Celular Tumoral , Femenino , Humanos , Diana Mecanicista del Complejo 1 de la Rapamicina , Ratones , Ratones Endogámicos BALB C , Complejos Multiproteicos/antagonistas & inhibidores , Fósforo , Sirolimus/química , Sirolimus/farmacología , Serina-Treonina Quinasas TOR/antagonistas & inhibidores , Ensayos Antitumor por Modelo de Xenoinjerto
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...